Discover Tenders by Access Gates Sector

Find the most relevant tenders for Access Gates. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Access Gates tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Access Gates tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Process

Deadline: 31 Dec 2026

Germany

Ref. No.: 13968963

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Interferon Beta 1B Atc Code According To Who L03Ab08

Deadline: 31 May 2026

Germany

Ref. No.: 13964497

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Process

Deadline: 31 Dec 2026

Germany

Ref. No.: 13964428

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By An Open House Model To The Active Ingredient Beclometason Formoterol Atc Code According To Who R03Ak08

Deadline: 31 May 2026

Germany

Ref. No.: 13957167

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Completion Not Excl Pharmaceutical Discount Club According To 130A Paragraph 8 Sgb V By Means Of An Open House Model To The Active Ingredient Epoetin Zeta Recombinant Human Erythropoetin

Deadline: 30 Apr 2027

Germany

Ref. No.: 13955053

EMD:Ref Document

Bid Value: Ref Document

334 Days Left

Housing Maintenance Repair

Deadline: 23 Jan 2027

United Kingdom

Ref. No.: 13935102

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Molizumab Vv 83

Deadline: 10 Feb 2027

Germany

Ref. No.: 13929656

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Fluorouracil Tolak Vv 83

Deadline: 10 Feb 2027

Germany

Ref. No.: 13929414

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 13927675

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Process

Deadline: 31 Dec 2026

Germany

Ref. No.: 13921788

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 13913990

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13845695

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Intravenous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13844974

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Certolizumab Pegol Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13788678

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Clostridium Botulinum Toxin A Xeomin Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13788654

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Showing 17161 to 17175 of 18092 results

‹
1
2
...
1142
1143
1144
1145
1146
1147
1148
...
1206
1207
›

Discover Tenders by Access Gates Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Access Gates Sector

Filter Your Search

FREE Trial plan for all new users!